With a short percentage of shares outstanding of 2.12%, UnitedHealth Group Incorporated (NYSE:UNH) is among the 7 Best Longevity and Anti-Aging Stocks to Buy.
On June 12, subsidiaries of UnitedHealth Group Incorporated (NYSE:UNH), including OptumRx and Emisar Pharma Services, reached an agreement with the Federal Trade Commission to settle allegations that the companies engaged in anticompetitive and unfair rebating practices related to insulin drug pricing
Under the agreement, the matter will be withdrawn from adjudication with respect to the Optum entities while the Commission evaluates a proposed consent agreement intended to fully resolve the claims against them. The Federal Trade Commission ordered that all proceedings involving the Optum respondents be stayed pending the Commission’s review and determination regarding the proposed settlement, representing a significant step toward resolving the regulatory matter. On June 8, JPMorgan raised its price target on UnitedHealth Group to $466 from $420 while maintaining an Overweight rating on the shares.
The firm updated its healthcare services models and increased its valuation outlook, reflecting continued confidence in the company’s long-term earnings potential and market position within the healthcare sector. Founded in 1974 and headquartered in Minnetonka, Minnesota, UnitedHealth Group operates through UnitedHealthcare for delivering health insurance and Optum for providing pharmacy benefits and care services. It funds healthy aging research through the United Health Foundation and expands Medicare Advantage to support longevity outcomes.